Form 4: Stem, Inc. Executive Matthew Tappin Sells Shares Under 10b5-1 Trading Plan

Matthew Tappin, President of Asset Management at Stem, Inc., sold 1,388 shares of common stock at $1.32 per share on May 28, 2024, under a pre-arranged trading plan.

Summary

• On May 28, 2024, Matthew Tappin, the President of Asset Management at Stem, Inc., sold 1,388 shares of the company's common stock.
• The shares were sold at a price of $1.32 per share.
• Following the transaction, Tappin directly owns 16,635 shares of Stem, Inc.
• The sale was executed under a Rule 10b5-1 trading plan adopted on November 13, 2023.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing an executive's stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

Executive stock sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on current inside information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.

Comparison to Industry Standards

• Executive compensation structures often include stock options and grants, leading to periodic sales of shares.
• The use of 10b5-1 trading plans is a standard practice among corporate executives to avoid accusations of insider trading.
• Comparing Tappin's transactions to those of executives at similar companies in the energy storage sector, such as Fluence or Tesla (Energy division), could provide additional context, but this would require further research into their individual filings.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, but is unlikely to be significant given the relatively small number of shares involved and the use of a 10b5-1 trading plan.

Key Dates